From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer
Cytomegalovirus (CMV) is a herpesvirus that establishes a persistent, but generally asymptomatic, infection in most people in the world. However, CMV drives and sustains extremely large numbers of antigen-specific T cells and is, therefore, emerging as an exciting platform for vaccines against infec...
Main Authors: | Nicole A. Wilski, Christopher M. Snyder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/7/3/62 |
Similar Items
-
Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation
by: Ranim El Baba, et al.
Published: (2021-09-01) -
The Human Cytomegalovirus, from Oncomodulation to Oncogenesis
by: Georges Herbein
Published: (2018-08-01) -
Interplay Between Calcium and AMPK Signaling in Human Cytomegalovirus Infection
by: Diana M. Dunn, et al.
Published: (2020-07-01) -
The oncomodulatory role of human cytomegalovirus in colorectal cancer: implications for clinical trials
by: Hsin-Pai eChen, et al.
Published: (2014-11-01) -
The role of CMV in glioblastoma and implications for immunotherapeutic strategies
by: Maryam Rahman, et al.
Published: (2019-01-01)